AG0036OW

944396-07-0 | 5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-pyridinamine

Chemical structure of 5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-pyridinamine, CAS 944396-07-0
AG0036OW
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 944396-07-0
Catalog Number AG0036OW(AGN-PC-01400W)
Chemical Name 5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-pyridinamine
IUPAC Name 5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine
InChI InChI=1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23)
InChI Key CWHUFRVAEUJCEF-UHFFFAOYSA-N
MDL Number MFCD18251596
Molecular Formula C18H21F3N6O2
Molecular Weight 410.3935
SMILES O1CCN(CC1)C1=NC(=CC(=N1)C=1C(=CC(=NC1)N)C(F)(F)F)N1CCOCC1
UNII 0ZM2Z182GD
Synonyms
BKM120, buparlisib, NVP-BKM120, 944396-07-0, Buparlisib, NVP-BKM120, BKM120, 5-(2,6-dimorpholinopyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine, BKM-120, NVP-BKM-120, BKM 120, 1202777-78-3, UNII-0ZM2Z182GD, NVP-BKM 120, 5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine, BKM120 (NVP-BKM120, Buparlisib), 5-[2,6-Di(Morpholin-4-Yl)pyrimidin-4-Yl]-4-(Trifluoromethyl)pyridin-2-Amine, 0ZM2Z182GD, CHEMBL2017974, CHEBI:71954, AK103313, 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-Pyridinamine, C18H21F3N6O2, 2-Pyridinamine,5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-, Buparlisib [USAN:INN], BKM 120NX, SD5, Buparlisib; BKM120, 3sd5, Buparlisib (USAN/INN), QCR-4, BKM120-NX, MLS006010984, SCHEMBL146956, GTPL7878, BKM120,NVP-BKM120, AMMD00049, CTK8C0567, BMK-120, DTXSID50241486, EX-A189, SYN1200, CWHUFRVAEUJCEF-UHFFFAOYSA-N, HMS3655D16, AOB87379, BKM120 (NVP-BKM120), BKM120 - NVP-BKM120, ABP000735, ANW-64908, BDBM50380363, MFCD18251596, s2247, ZINC43154039, AKOS016005372, ACN-031536, AM85983, BCP9001011, CS-0089, DB11666, RL05935, SB16577, BKM120 (NVP-BKM120 Buparlisib), Buparlisib (BKM120, NVP-BKM120), NCGC00262604-01, NCGC00262604-08, 4CA-0929, AN-26178, AS-40568, BC638775, HY-70063, SMR004702786, AB0008183, AJ-108243, AX8234852, DB-079882, ST2411649, TC-153653, FT-0755923, SW218149-2, X7578, KS-00000637, A25436, D10584, W-5735, J-516601, BRD-K42191735-001-01-2, 4-(trifluoromethyl)-5-(2,6-dimorpholinopyrimidin-4-yl)pyridin-2-amine, 5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine, 5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine, 2-Pyridinamine, 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-, 5-(2,6-di-morpholin-4-yl-pyrimidin-4-yl)-4-trifluoromethyl-pyridin-2-ylamine, 5-[2,6-bis(morpholin-4-yl)pyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine, Buparlisib [INN], D01QSO, cc-258, A3015, A11016, C571178, Buparlisib, 98%, a selective PI3K inhibitor - 1G 1g, 1312445-63-8,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited